Want to see GB:FEVR full AI Analyst Report?
Top Page
Fevertree Drinks
(LSE:FEVR)
Select Model
Select Model
Rating:64Neutral
Price Target:
851.00 p
▼(-0.23% Downside)
Action:Reiterated
Date:09/15/26
The score is driven primarily by solid underlying financial resilience (notably the very strong, low-leverage balance sheet) and a very constructive earnings-call outlook pointing to accelerating U.S. growth and meaningful medium-term profit uplift. Offsetting these positives are weak current technical momentum and a high P/E that leaves less room for near-term execution risk, especially given recent margin compression and cash-flow volatility.
Positive Factors
Very low leverage
Debt-to-equity of about 0.02 and substantial equity give Fever-Tree considerable financial flexibility. This low-leverage profile limits financing pressure, supports continued investment in brand and distribution, and provides resilience if trading conditions weaken.
Negative Factors
Revenue and margin deterioration
Recent top-line contraction alongside materially lower gross and net margins weakens the quality of the earnings trajectory. Unless growth and profitability recover, reduced operating leverage could constrain reinvestment, limit earnings expansion, and make results more sensitive to execution.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low leverage
Debt-to-equity of about 0.02 and substantial equity give Fever-Tree considerable financial flexibility. This low-leverage profile limits financing pressure, supports continued investment in brand and distribution, and provides resilience if trading conditions weaken.
Read all positive factors
Fevertree Drinks (FEVR) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£933.60M
Dividend Yield2.06%
Average Volume (3M)294.06K
Price to Earnings (P/E)39.0
Beta (1Y)1.16
Revenue Growth1.74%
EPS Growth2.83%
CountryUK
Employees285
SectorConsumer Defensive
Sector Strength42
IndustryBeverages - Non-Alcoholic
Share Statistics
EPS (TTM)0.22
Shares Outstanding111,077,170
10 Day Avg. Volume482,354
30 Day Avg. Volume294,060
Financial Highlights & Ratios
PEG Ratio-4.53
Price to Book (P/B)4.42
Price to Sales (P/S)3.03
P/FCF Ratio32.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£957.00Price Target Upside12.19% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.28
Revenue Forecast (FY)£400.71M
Fevertree Drinks Business Overview & Revenue Model
Company Description
Fevertree Drinks Plc, together with its subsidiaries, specializes in crafting and distributing premium mixer beverages across the United Kingdom, the United States, Europe, and other international markets. Its diverse product portfolio includes po...
How the Company Makes Money
Fevertree makes money by selling branded premium mixers and related soft drinks to customers in different geographies, generating revenue primarily from the wholesale distribution of finished beverages. Its key revenue stream is product sales volu...
Fevertree Drinks Earnings Call Summary
Earnings Call Date:Sep 10, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Mar 30, 2027
Earnings Call Sentiment Positive
The call was strongly positive. Management reported broad-based first-half growth, improving margins and EPS, accelerating U.S. momentum, successful diversification, strong cash generation, and confidence in a circa 60% EBITDA uplift over the next two years. The main challenges were the expected short-term U.S. margin impact from elevated marketing investment, the GBP 2.6 million EPR provision, U.K. on-trade challenges, European revenue phasing, and delayed working-capital benefits from U.S. onshoring.Positive Updates
Strong First-Half Group Performance
Brand revenue increased by 8% at constant currency, with growth across every key region. The U.S. grew 11%, Europe grew 10%, the U.K. returned to growth, and the rest of the world made good progress.
Negative Updates
U.S. EBITDA Margin Decline
U.S. EBITDA margin reduced as expected, largely reflecting up-weighted marketing investment. Management said incremental U.S. marketing investment is expected to moderate to more typical levels over the medium term.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong First-Half Group Performance
Brand revenue increased by 8% at constant currency, with growth across every key region. The U.S. grew 11%, Europe grew 10%, the U.K. returned to growth, and the rest of the world made good progress.
Read all positive updates
Company Guidance
For FY 2026, Fever-Tree expects U.S. revenue growth to accelerate as the year progresses, the rest of the group to deliver good underlying growth, reported revenue in Europe to be impacted as phasing benefits from the first half of the year unwind, and EBITDA to be in line with expectations; U.S. tariff refunds received in the second half will offset the full-year impact of the incremental GBP 2.6 million EPR provision, working capital will be similar year-on-year and significantly below historic levels, and the company remains confident of delivering high teens, 20% growth in the U.S. next year, with U.S. and group profitability expected to see a step change in 2027 and 2028, supporting consensus expectations of the circa 60% uplift in EBITDA over the next two years and at least GBP 100 million of free cash flow across 2027 and 2028; group EBITDA margin is expected to move from about 12.5% this year to high 14%-15%.Fevertree Drinks Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
88
Very Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 345.80M | 325.00M | 368.50M | 364.40M | 344.30M | 311.10M |
| Gross Profit | 106.80M | 107.30M | 138.40M | 109.00M | 118.80M | 130.90M |
| EBITDA | 38.80M | 36.90M | 45.70M | 30.80M | 37.20M | 60.60M |
| Net Income | 25.20M | 22.60M | 24.40M | 15.40M | 24.90M | 44.60M |
Balance Sheet | ||||||
| Total Assets | 266.00M | 287.00M | 321.90M | 313.70M | 311.60M | 336.10M |
| Cash, Cash Equivalents and Short-Term Investments | 68.00M | 91.10M | 96.00M | 59.90M | 95.30M | 166.20M |
| Total Debt | 3.80M | 3.80M | 12.10M | 15.20M | 16.90M | 2.90M |
| Total Liabilities | 64.70M | 63.90M | 75.20M | 75.90M | 72.40M | 54.50M |
| Stockholders Equity | 201.30M | 223.10M | 246.70M | 237.80M | 239.20M | 281.60M |
Cash Flow | ||||||
| Free Cash Flow | 31.30M | 30.30M | 56.10M | -13.40M | 1.40M | 42.20M |
| Operating Cash Flow | 35.60M | 33.60M | 70.20M | -3.80M | 8.50M | 46.80M |
| Investing Cash Flow | -3.70M | 13.10M | -10.80M | -9.60M | -10.00M | -4.30M |
| Financing Cash Flow | -94.10M | -51.20M | -23.60M | -23.10M | -70.70M | -19.30M |
Fevertree Drinks Technical Analysis
Positive
853.00
Price Trends
834.48
Positive
814.00
Positive
826.80
Positive
Market Momentum
-2.62
Negative
52.91
Neutral
84.51
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:FEVR, the sentiment is Positive. The current price of 853 is above the 20-day moving average (MA) of 828.48, above the 50-day MA of 834.48, and above the 200-day MA of 826.80, indicating a bullish trend. The MACD of -2.62 indicates Negative momentum. The RSI at 52.91 is Neutral, neither overbought nor oversold. The STOCH value of 84.51 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:FEVR.
Fevertree Drinks Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £413.15M | 17.38 | 24.74% | 3.44% | 2.73% | 37.06% | |
68 Neutral | £15.48B | 17.94 | 25.10% | 2.41% | 12.76% | 12.70% | |
64 Neutral | £933.60M | 38.97 | 11.88% | 2.06% | 1.74% | 2.83% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | £669.71M | 14.33 | 14.27% | 3.11% | 4.02% | 18.51% | |
54 Neutral | £382.33M | 145.81 | 0.62% | 4.80% | -3.68% | -76.00% | |
50 Neutral | £78.90M | 353.85 | 0.71% | ― | 18.91% | ― |
* Consumer Defensive Sector Average
GB:FEVR
Fevertree Drinks
840.50
-35.56
-4.06%
GB:BAG
AG Barr
602.00
-55.30
-8.41%
GB:CCH
Coca Cola HBC
4,248.00
739.66
21.08%
GB:NICL
Nichols
1,130.00
-48.45
-4.11%
GB:CCR
C&C Group Plc
103.80
-35.55
-25.51%
GB:CDGP
Chapel Down Group plc
46.00
4.00
9.52%
Fevertree Drinks Corporate Events
Business Operations and StrategyStock Buyback
Fever-Tree Moves to Cancel Shares After Targeted Buyback
Positive
Sep 15, 2026
Fever-Tree Drinks has moved to buy back its own shares, purchasing ordinary stock through Investec Bank between 7 and 11 September on the London Stock Exchange’s main market and AIM. The programme, executed under shareholder authority grante...
Business Operations and StrategyRegulatory Filings and Compliance
Fever-Tree chair boosts stake with share purchase on London market
Positive
Sep 14, 2026
Fever-Tree, the premium mixers producer, reported that its non-executive chair, Domenic De Lorenzo, has increased his stake in the company through a share purchase on the London Stock Exchange. He acquired 44,674 ordinary shares at an average pric...
Other
Fever-Tree Chair Increases Stake with Share Purchase
Positive
Sep 14, 2026
Fever-Tree Drinks reported that its Non-Executive Chair, Domenic De Lorenzo, has acquired 44,674 ordinary shares in the company on the London Stock Exchange. The shares were purchased on 11 September 2026 at an average price of £7.7955, in a ...
Business Operations and StrategyStock BuybackFinancial Disclosures
Fevertree lifts revenues and earnings as U.S. and U.K. growth gather pace
Positive
Sep 10, 2026
Fevertree Drinks reported interim results for the six months to 30 June 2026 showing Fever-Tree brand revenue up 8% at constant currency to £183.6 million, with growth across all regions and record retail market share in ginger beer and tonic...
Business Operations and StrategyStock Buyback
Fever-Tree Moves to Cancel Shares After Early September Buyback
Positive
Sep 8, 2026
Fevertree Drinks plc has repurchased a series of ordinary shares on both the London Stock Exchange and AIM between 1 September and 4 September 2026 under authority granted at its 2025 AGM. The trades, executed via broker Investec Bank, were carrie...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels Shares After Late-August Buyback Spree
Positive
Sep 2, 2026
Fevertree Drinks has launched a share buyback programme, purchasing tens of thousands of ordinary shares on the London Stock Exchange and AIM between 24 and 28 August 2026 at volume-weighted average prices around 851–860 pence. The company h...
Regulatory Filings and Compliance
Fever-Tree Clarifies Total Voting Rights and Share Capital Structure
Neutral
Sep 1, 2026
Fever-Tree Drinks has confirmed that its total issued share capital comprises 111,504,742 ordinary shares, each carrying one voting right, and that it holds no shares in treasury. The declaration sets the official total number of voting rights at ...
Business Operations and StrategyStock Buyback
Fevertree Drinks to Cancel Shares After August Buyback Programme
Positive
Aug 25, 2026
Fevertree Drinks plc has initiated a share buyback programme, purchasing a series of ordinary shares on the London Stock Exchange and AIM between 17 August and 21 August 2026 through its broker Investec Bank. The transactions were executed under s...
Business Operations and StrategyStock Buyback
Fever-Tree Launches Share Buyback and Plans Cancellation of Repurchased Stock
Positive
Aug 18, 2026
Fevertree Drinks plc has repurchased a series of ordinary shares between 10 and 14 August 2026 on the London Stock Exchange’s main market and AIM, acting under a previously approved shareholder authority. The trades, executed via Investec Ba...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels Shares After August Buyback Programme
Positive
Aug 11, 2026
Fever-Tree Drinks plc has been actively repurchasing its own ordinary shares, executing buybacks through Investec Bank on London venues between 3 August and 7 August 2026. The trades were conducted under authority granted at the 2025 annual meetin...
Business Operations and StrategyStock Buyback
Fevertree Cancels Shares After New Buyback Round
Positive
Aug 4, 2026
Fevertree Drinks has launched a share buyback, purchasing ordinary shares on the London Stock Exchange and AIM between 27 July and 31 July 2026 through Investec Bank. The trades were executed at volume-weighted average prices in the low- to mid-80...
Regulatory Filings and Compliance
Fever-Tree Confirms Total Voting Rights at 112.3 Million Shares
Neutral
Aug 3, 2026
Fever-Tree Drinks has confirmed that its total issued share capital stands at 112,264,945 ordinary shares of 0.25p each, with one voting right per share and no shares held in treasury. This establishes the company’s total voting rights at 11...
Business Operations and StrategyStock Buyback
Fevertree cancels shares after July buyback on London markets
Positive
Jul 28, 2026
Fevertree Drinks plc has repurchased a series of its own ordinary shares between 20 and 24 July 2026 via its broker Investec Bank, under the authority granted at its 2025 annual meeting. The buybacks, executed across the London Stock Exchange̵...
Business Operations and StrategyStock Buyback
Fever-Tree Moves to Cancel Shares After Latest Buyback Round
Positive
Jul 21, 2026
Fevertree Drinks plc has executed a share buyback programme under authority granted at its 2025 annual general meeting. The company purchased ordinary shares across London Stock Exchange venues between 13 and 17 July 2026 at volume-weighted averag...
Delistings and Listing ChangesRegulatory Filings and Compliance
Fever-Tree Updates Block Listing Return for Employee Share Schemes
Neutral
Jul 15, 2026
Fever-Tree has reported an updated block listing return for its Long Term Incentive Plan and Savings Related Share Option Scheme covering the period from 2 December 2025 to 14 July 2026. During this time, the company allotted a total of 127,128 sh...
Business Operations and StrategyStock Buyback
Fever-Tree cancels shares after latest buyback on London markets
Positive
Jul 14, 2026
Fevertree Drinks plc has repurchased a series of its own ordinary shares between 6 July and 10 July 2026 on the London Stock Exchange’s main market and AIM, acting through its broker Investec Bank. The buyback was executed under shareholder ...
Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Fever-Tree Cancels Newly Repurchased Shares in Ongoing Buyback Programme
Positive
Jul 7, 2026
Fevertree Drinks plc, the premium mixer company behind the Fever-Tree brand, supplies tonic waters and other carbonated mixers to bars, restaurants and retailers, targeting consumers seeking higher-quality alternatives in the soft drinks segment. ...
Regulatory Filings and Compliance
Fever-Tree Clarifies Total Voting Rights as Share Capital Reaches 113 Million Shares
Neutral
Jul 1, 2026
Fever-Tree Drinks plc has confirmed that its total issued share capital stands at 113,111,956 ordinary shares, each carrying one vote, and that it holds no shares in treasury. As a result, the company’s total number of voting rights is 113,1...
Business Operations and StrategyStock Buyback
Fevertree extends share buyback to £60m as capital return accelerates
Positive
Jul 1, 2026
Fevertree Drinks, the UK-based producer of premium carbonated mixers, distributes its range of tonic and other mixer products to over 95 countries worldwide. The company targets both on-trade venues such as hotels, bars and restaurants, and off-tr...
Business Operations and StrategyExecutive/Board Changes
Fever-Tree reshapes board as Non-Executive Director Laura Hagan steps down
Neutral
Jun 30, 2026
Fever-Tree Drinks plc, a UK-based premium beverage company, is the world’s leading supplier of high-quality carbonated mixers for alcoholic spirits, distributing its products to on-trade venues and off-trade retailers in more than 90 countri...
Business Operations and StrategyStock Buyback
Fevertree Drinks Launches Share Buyback and Plans Cancellation of Repurchased Stock
Positive
Jun 30, 2026
Fevertree Drinks has executed a series of share buybacks between 22 and 26 June 2026 on AIM and the London Stock Exchange under an authority granted at its 2025 annual meeting. The trades, carried out through broker Investec Bank, involved multipl...
Business Operations and StrategyStock Buyback
Fever-Tree Cancels Newly Repurchased Shares After June Buyback
Positive
Jun 30, 2026
Fevertree Drinks plc has executed a series of share repurchases between 22 and 26 June 2026 on AIMX and the London Stock Exchange, buying back tens of thousands of ordinary shares at prices generally in the high 700p to low 800p range. The program...
Business Operations and StrategyStock Buyback
Fevertree Cancels Newly Repurchased Shares After June Buyback
Positive
Jun 23, 2026
Fevertree Drinks has carried out a series of share buybacks under authority granted at its 2025 AGM, purchasing multiple tranches of ordinary shares on the AIM and London Stock Exchange between 15 and 19 June 2026 at volume‑weighted average ...
Stock Buyback
Fevertree Cancels Shares After Mid-June Buyback on London Markets
Positive
Jun 16, 2026
Fevertree Drinks has repurchased a tranche of its own ordinary shares under the authority granted at its 2025 annual meeting, executing buybacks on AIM and the London Stock Exchange between 8 and 12 June 2026. The company plans to cancel the repur...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.